Amicus Therapeutics (FOLD)
(Delayed Data from NSDQ)
$9.33 USD
+0.29 (3.21%)
Updated May 14, 2024 04:00 PM ET
After-Market: $9.32 -0.01 (-0.11%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth D Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.06 | -8.33% |
Earnings Summary
For their last quarter, Amicus Therapeutics (FOLD) reported earnings of -$0.02 per share, beating the Zacks Consensus Estimate of $-0.06 per share. This reflects a positive earnings surprise of 66.67%. Look out for FOLD's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.06 per share, reflecting a year-over-year increase of 60%.
Earnings History
Price & Consensus
Zacks News for FOLD
Amicus Therapeutics (FOLD) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
FOLD: What are Zacks experts saying now?
Zacks Private Portfolio Services